Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

QUALCOMM, Inc. (QCOM): Despite Lower Earnings Guidance, This Chipmaker Is a Buy

Page 1 of 2

QUALCOMM, Inc. (NASDAQ:QCOM) is benefiting from the increasing demand for smartphones and the growing focus of network operators worldwide to implement high-speed wireless technology, popularly known as LTE, or long-term evolution.

The chip maker’s stock has been a bit volatile lately. Despite record earnings, shares fell 7% due to the company’s lower-than-expected earnings outlook for the upcoming quarter. Since then, the stock has moved up in line with market expectations. So, where will the stock move from here?

Growth drivers

QUALCOMM, Inc.QUALCOMM, Inc. (NASDAQ:QCOM) has teamed up with Japan’s Sharp to mass produce displays for mobile devices, and those components have the potential for much faster response times and use a fraction of the power required by LCDs. However, manufacturing cost is the main concern here, and if the company manages to control the cost, this technology will prove an important weapon in developing markets.

The chip maker continues to up its R&D spending to take advantage of new market opportunities, such as tablets. QUALCOMM, Inc. (NASDAQ:QCOM) spent $1.88 billion on R&D and SGA expenses in the second quarter, which is a 21% jump from the same period a year ago and an increase of 11% sequentially. For the current quarter, the company expects a 2%-4% rise in R&D spending.

Until now, major devices like Samsung’s Galaxy S4, the HTC One, and the Sony Xperia Z, were using Snapdragon 600, but the more powerful Snapdragon 800 will now be used in tablets and phablet devices. The initial responses show that Snapdragon 800 is much more powerful and equally efficient, and will go a long way to enhance offerings from the chip maker.

QUALCOMM, Inc. (NASDAQ:QCOM) not only makes chips for high-end devices like the iPhone and Galaxy lineup, but its offerings are also used in lower-priced handsets popular in Asia and other emerging markets. These markets will help the company to carry on the growth trend once the U.S. market saturates. However, lower end devices command a lower margin for Qualcomm, as manufacturers pay fewer royalties and acquire cheaper components.

Comparison with rivals

Share Price* 52-Week Range PE Forward PE ROE
BRCM 33.77 28.60 – 37.85 23.41 10.67 11.02%
INTC 24.06 19.23 – 26.90 11.88 11.76 21.06%
QCOM 60.95 53.09 – 68.50 17.09 12.41 17.87%

*as of June 5, 2013.

Broadcom Corporation (NASDAQ:BRCM) and Intel Corporation (NASDAQ:INTC) are QUALCOMM, Inc. (NASDAQ:QCOM)’s closest competitors. Shares of all three firms are trading in the upper range of their respective 52-week highs, reflecting positive sentiment for the industry. For Broadcom, PE looks slightly higher, making it a bit more expensive, while Intel and Qualcomm look decently valued. Forward PE for both Broadcom Corporation (NASDAQ:BRCM) and Qualcomm reflects that earnings are expected to rise for these two. For Intel Corporation (NASDAQ:INTC), there is a slight change in forward PE, suggesting earnings are expected to be flat. Intel commands the highest ROE among the three, followed by Qualcomm.


The advantage enjoyed by the chip maker in the LTE segment may soon wither as an increasing number of smaller players are attracted to the high-growth market. These players will be a major challenge for QUALCOMM, Inc. (NASDAQ:QCOM) in the developing countries, as they are improving on technology and are ready to adjust on profits in exchange for market share.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!